chrisvoncsefalvay/vaers-outcomes huggingface dataset:
neurological issues/She states she is in the traumatic brain injury category; fatigue level increasing; difficulty concentrating; migraine; postural dizziness; visual disturbances; extreme sensitivity to any type of light, light was intolerable to her in May2021; extreme sensitivity in her ears, she didn't hear sounds, she felt the vibrations that the sounds made; paresthesia; numbness has been more on her right side than her left side; shooting pain primarily in her head; foot now is rather painful and tender; Her right leg doesn't work exactly as it should; worsening headache; hematuria; acute urinary tract infection; sinusitis; yeast infection; increased urinary frequency; allergic reaction to insect bites; neurological issues; This is a spontaneous report from a contactable consumer, the patient. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EP7534, expiration Date: 31Jul2021), dose 1 via an unspecified route of administration, administered in arm right on 17Mar2021 as dose 1, single and dose 2 via an unspecified route of administration, administered in arm right on 07Apr2021 (lot number: ER8734, expiration date: 31Jul2021) as dose 2, single for (at the age of 52-years-old) covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took flu vaccine about 3 weeks prior to the first Covid 19 vaccine. On an unknown date in Mar2021, the patient had difficulty concentrating, migraine, postural dizziness, visual disturbances, extreme sensitivity to any type of light, light was intolerable to her in May2021, and extreme sensitivity in her ears, she didn't hear sounds, she felt the vibrations that the sounds made. She also had paresthesia. She reports the numbness has been more on her right side than her left side. She also has shooting pain primarily in her head. She states she had injured a nerve in her left foot prior to receiving either Covid 19 vaccine and that foot now is rather painful and tender in the morning. Her right leg did not work exactly as it should. She was not dragging her right leg but from the time she got the first Covid 19 vaccine her right leg was not working properly. The patient experienced the worsening headaches, hematuria, acute urinary tract infection, sinusitis, yeast infection, allergic reaction to insect bites, and increased urinary frequency. The patient was in the traumatic brain injury category and her fatigue level was increasing. The patient was seen by her primary care doctor and went to and Urgent Care on 07Apr2021 after getting the second dose and the emergency department on 08Apr2021. She was not hospitalized. The bright side is, she's still alive. Her sister was the one who wheeled her in to the emergency department after her reaction but she is equally satisfied that she received the second Covid 19 vaccine. On an unknown date, bloodwork, CT scan without contrast, CT scan with contrast and autonomic test was performed but results were not reported. The outcome of the events was recovering.
Information has been received from a consumer concerning her 8 month old son, with no medical history and no allergies, who was vaccinated with a first and second oral dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live on 8/15/06 and 9/14/06, respectively. Concomitant therapy included ranitidine HCl and cetirizine hydrochloride. it was reported that on the evening of 10/22/06 the patient was lethargic, had blood in his stool, was vomiting with dried black blood, and was dehydrated. A physician diagnosed the patient with intussusception that was about 8mm in length on the morning of 10/23/06 and was hospitalized. It was reported that the patient had to have emergency surgery for a bowel resection. The reporter noted that the surgeon indicated that the patient also had a swollen lymph node about the size of a shooter marble and he believed that it may have been related to the experience. At the time of the report, it was noted that the patient was doing much better. The patient's experience was considered to be immediately life-threatening and disabling by the reporter. Additional information has been requested.  11/27/06 Received medical records from hospital which reveal patient admitted 10/23/06 with nausea, vomiting & colicky symptoms.  Barium enema did not reduce IS & patient taken to surgery for reduction of IS with ileocecal resection & appendectomy.  Continued to improve w/o further complication & was d/c to home on 10/27/06. PMH: GERD, URIs Final Dx: Intussusception (IS) and chronic reflux. Patient was readmitted for overnight observation & hydration on 10/28-10/29/06 after running a fever of 102 for approx 1 day.  It was felt to be a viral infection./ss
Pt was vaccinated 1/8/21 and 2/5/21 and was later hospitalized on 11/29-12/9 and pt died.
I started having heart palpitations and it went on for a few weeks. I went to the doctor and the emergency they gave me a couple of medications and it never went away.
3:56pm Client passed out while on observation.  Client evaluated by EMS on site. 4:03pm Client transported to Hospital awake.  BP 100/80, P 45, R 20, )2 97 with oxygen via mask.
16 year old client received Moderna COVID 19 vaccine as a booster by parent request.
Information has been received from a physician referring to his/her child, an adult patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant therapies were not reported. It was reported that because the physician used primarily a combined vaccine, he/she did not routinely use the separate hepatitis B doses for his/her pediatrics population. The physician further reported that his/her child was transferred from another practice where the 3rd dose of hepatitis B vaccine (manufacturer unknown) (lot #, expiration date, dose and route were not reported) was missed during routine immunizations. The physician wanted to know how to get one dose of hepatitis B vaccine rather than buying 10 and throwing away 9 doses. Additional information has been requested.
Soon after my 2nd shot I noticed a nerve type pain in my left breast.  On 9/27 my annual mammogram showed an asymmetry in my left breast requiring further testing.  On 10/11 further mammogram and ultrasound of my left breast showed a cyst and an enlarged lymph node which are probably benign per the report and my gyn. Previous mammogram in September 2020 was normal. Left breast pain is still present today.
Hospitalized (10.13.21);  COVID-19 positive (10.13.21);  fully vaccinated   Admission Date: 10/13/2021 Discharge Date: Oct 15, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 68-year-old male without medical history of chronic obstructive pulmonary disease on chronic 2 L oxygen, paroxysmal atrial fibrillation, hypertension, mi BPH, GERD he presented to the hospital with acute on chronic hypoxic respiratory failure and at generalized complaints of fatigue.  He patient was admitted to the hospital for an acute exacerbation of chronic obstructive pulmonary disease.  He was also found to be COVID positive patient was vaccinated with Pfizer vaccine in February of 2021. Patient did have an x-ray performed in the hospital which did not reveal evidence of infiltrate.  Patient was admitted to the hospital treated with dexamethasone, remdesivir.  He did well with treatment.  His oxygen requirement decreased back to his baseline and he was no longer having any symptoms of fevers or chills.  He was feeling well enough to be discharged home.  Patient was treated for elevated hypertension in the hospital he was started on Norvasc which she is to continue outpatient and follow-up with his primary care physician Discharge diagnosis:   1. Acute on chronic hypoxic respiratory failure- secondary to his underlying COPD with now acute excerebration with superimposed covid 19 infection.  2. -COVID-19  3. Hypertension accelerated 4. Paroxysmal atrial fibrillation 5. GERD
Patient recently had shingles & presented w/similar, but less severe symptoms; including headache & swollen left side of face.
pt felt joint pain on day 1 and lung tightness that resolved quickly on day 3
received 2nd dose on 28Jan2021/experienced sore arm the first day; First Dose: arm was sore; This is a spontaneous report from a contactable consumer (patient's wife). A 66-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on the arm, first dose on 07Jan2021 and then second dose on 28Jan2021, at single dose, COVID-19 vaccination. The patient's medical history and concomitant medications were not reported. The patient's wife and patient both went to get their first dose of the COVID vaccine on 07Jan2021, through a drive thru site and reported that the next day (08Jan2021), their arms were sore, but it was okay, nothing bad. The patient's wife heard Dr. (name) saying that the second dose is really bad. When they went for their second dose on 28Jan2021, the patient had a sore arm the first day, that resolved but the patient's wife had no symptoms. She doubt that the person that gave her the vaccine because she didn't feel anything and had zero symptoms. She feel frightened, scared, worried and regret going there and stated that they need to train these people. The person that vaccinated her did put the needle but didn't push the plunger. She also asks if they should  get an antibody test after the vaccine. The outcome of the event was recovered.   Information on the Lot/Batch number has been requested.
Missed second dose of the Moderna COVID-19 vaccine; Spontaneous abortion; Lot of pain in my whole arm; Exposure during pregnancy; Strong headache; Pain in the muscle where I got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ABORTION SPONTANEOUS (Spontaneous abortion) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (Lot of pain in my whole arm), EXPOSURE DURING PREGNANCY (Exposure during pregnancy), HEADACHE (Strong headache) and VACCINATION SITE PAIN (Pain in the muscle where I got the vaccine). On 08-Apr-2021, the patient experienced ABORTION SPONTANEOUS (Spontaneous abortion) (seriousness criterion medically significant). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose of the Moderna COVID-19 vaccine). The patient was treated with IBUPROFEN (oral) at a dose of 500 mg. At the time of the report, ABORTION SPONTANEOUS (Spontaneous abortion), PRODUCT DOSE OMISSION ISSUE (Missed second dose of the Moderna COVID-19 vaccine), PAIN IN EXTREMITY (Lot of pain in my whole arm), EXPOSURE DURING PREGNANCY (Exposure during pregnancy), HEADACHE (Strong headache) and VACCINATION SITE PAIN (Pain in the muscle where I got the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  This is a case of product exposure during pregnancy with associated AEs for this 28-year-old female. Very limited information regarding this events has been provided at this time. Further information has been requested.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Followup received contains NNI; Sender's Comments: This is a case of product exposure during pregnancy with associated AEs for this 28-year-old female. Very limited information regarding this events has been provided at this time. Further information has been requested.
We gave the vaccine 2 days after the expiration date / Patient received an expired dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We gave the vaccine 2 days after the expiration date / Patient received an expired dose) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (We gave the vaccine 2 days after the expiration date / Patient received an expired dose). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (We gave the vaccine 2 days after the expiration date / Patient received an expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided. No Treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Nov-2021: Significant follow-up appended contains Patient details and Reporter information added
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Apr2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "hbp" (unspecified if ongoing). The patient's concomitant medications were not reported. The patient did not receive any other medication in 2weeks. The patient had no known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 TREATMENT (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 treatment.  Clinical Course: The patient received Paxlovid for COVID 19 treatment. The treatment start date was 06Jul2022 and stop date was 10Jul2022. The patient experienced diarrhea fairly severe, and burnt terrible taste in mouth to Paxlovid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
LESS THAN 24 HOURS LATER I AWAKENED WITH A SWOLLEN RIGHT EYELID AND HIVES ALL OVER MY FACE.  THE SITE OF THE INJECTION WAS HOT, RED AND SLIGHTLY RAISED.  FIVE DAYS LATER I STILL HAVE SOME HIVES BUT THEY ARE GETTING SMALLER. THE EYE LID SWELLING IS GONE BUT THE EYE LID IS ITCHY.  CHILDREN'S LIQUID BENADRYL USED FOR 3 DOSES OF 1 1/2 TABLESPOONS AT A TIME.
blood spike electrophoresis; severe tiredness; swollen left arm where she got injected; headache; diarrhea; dizziness; hurt all over body; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DIZZINESS (dizziness), PAIN (hurt all over body), ELECTROPHORESIS (blood spike electrophoresis) and VACCINATION SITE SWELLING (swollen left arm where she got injected) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0ZSADIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma. Concurrent medical conditions included Penicillin allergy. Concomitant products included VITAMIN D NOS, CENTRUM FOR WOMEN, LANSOPRAZOLE (PREVACID) and ESTRADIOL (ESTROGEN) for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced DIARRHOEA (diarrhea), DIZZINESS (dizziness), PAIN (hurt all over body), VACCINATION SITE SWELLING (swollen left arm where she got injected) and HEADACHE (headache). On an unknown date, the patient experienced ELECTROPHORESIS (blood spike electrophoresis) and FATIGUE (severe tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), DIZZINESS (dizziness), PAIN (hurt all over body), ELECTROPHORESIS (blood spike electrophoresis), VACCINATION SITE SWELLING (swollen left arm where she got injected) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: New adverse event of severe tiredness
Patient had NOT had a previous primary series of Pfizer for COVID and was given a bivalent dose of Pfizer. No adverse reaction- this is an administration error.
Patient became faint about 5 minutes after receiving both vaccinations. She then slumped backwards in the chair and then had a small, mild seizure.
I haven't taken the 2nd vaccine yet.; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I haven't taken the 2nd vaccine yet.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I haven't taken the 2nd vaccine yet.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I haven't taken the 2nd vaccine yet.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment and concomitant medications were provided.
Within 15 minutes of 2nd shot had significant pins and needles (and some numbness) in right leg most significantly below knee in calf to foot area - this persisted for approximately 24 hours.  Typical flu like symptoms (aches)/fever along with slight cough with phlegm occurred from 18-48 hours as these resolved patient was left with significant and persistent pain in chest  on day 3 post vaccination.  This pain persisted and spread to neck, back, jaw.  Ultimately due to persistent pain patient went to a hospital emergency room for evaluation.  Nuclear stress came back abnormal and patient was admitted for further evaluation but eventually released  to follow up with cardiologist. Patient currently following up with medical professionals for continuing care for suspected myocarditis.
pt recd vax & developed measles rash, cough, coryza, conjunctivitis, & Koplik spots.
Pt complained of weakness from waist up that got progressively worse form 06/20 to 06/21. Unable to drive. Complained of pain from waist to head. He was started on Decadron, 4 mg IV BID. IV fluids at 150 u/L. Continuous pulse ox.
Patient c/o sore arm on 2-28-09.  Mom noted redness, inflammation & warmth.  Dad took patient to walk-in clinic on 2/28/09.  Dr. put him on antibiotic.
Pain at injection site, chills, cough, sore throat, runny nose, congestion, headache, fatigue, nausea, delirium, chest pain for 4 days now.
Case number PHEH2015US021588 is an initial spontaneous report received from a health care professional on 21 Oct 2015. This report refers to a 56 year old male patient. Medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1516401) intramuscularly, whose vial was leaking where the diaphragm and metal ring meet on 15 Oct 2015. The case was assessed as non-serious. No adverse event was reported following this medication error.
Patient developed hives 2 days after receiving GARDASIL vaccine - hives have lasted 1 wk, pt to be treated with steroids.
Felt a mild itch. When touched felt a rised area that was harder then skin. Similar to a bug bite. Over the few hours has gotten more red in colour.  The night before around 2100 felt a wave of fatigue and a few chills.  Thought it was from having a busy day and bipolar weather.
adipose necrosis-1x1cm <less; pt exp dimpling of thigh p/vax;dimpling is a result of necrosis of fatty tissue;
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization/Death. Rec'd Pfizer BioNTech vaccine on 4/29/21 and 5/27/21. Presented to ED after O2 level checked dropped to 70% at home. Admitted w/septic shock, Covid, PNA, anion gap acidosis, UTI, leukocytosis. She was intubated, IV abx's, fluid resuscitation, steroids, refractory shock on 3 pressors, anuria, and max vent settings. CXR revealed PNA. Transitioned to comfort care; expired 9/19/22. Tx'd with decadron, azithromycin, zosyn, and vancomycin.
very brain fogged; sensation of feeling high; exhausted; need multiple naps per day; rash on my stomach; This is a spontaneous report from a contactable consumer (patient). This 35-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0169) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety from an unknown date and unknown if ongoing. Prior to vaccination the patient had not been diagnosed with COVID-19 and had not received any other vaccines in the 4 weeks prior to the COVID vaccine. Concomitant medications included sertraline from an unknown date for an unknown indication, and loratadine (CLARITIN "OTC") from an unknown date for an unknown indication. The patient previously received the first dose of BNT162B2 (lot number ER8734) on 31Mar2021 (at the age of 35-years-old) for COVID-19 immunisation. The patient reported that within 2 hours after vaccination she became very brain fogged which then turned into a sensation of feeling high; further reporting she could not stop laughing for an hour and was super high for another 4 hours. She reported that also on day 3, "now," and she was still exhausted and needed multiple naps per day. She also reported she had a rash on her stomach. The events were reported as non-serious and no treatment was received. The clinical outcomes of very brain fogged and sensation of feeling high were recovering and the outcomes of exhausted, need multiple naps per day and rash on her stomach were not recovered. It was also reported that since vaccination the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Patient is having pain in right arm 10 days post-vaccination in shoulder joint, toward top of the arm.
This case was reported by a consumer via call center representative and described the occurrence of itchy upper limbs in a adult male patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included paraplegia (Patient is a paraplegic and has neurological issues). On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced itchy upper limbs. On an unknown date, the outcome of the itchy upper limbs was unknown. It was unknown if the reporter considered the itchy upper limbs to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter spoke to a friend whose husband received SHINGRIX vaccine. The patient experienced itching on his arms after receiving the vaccination. No additional details were available. The patient had denied permission to contact their physician. This case is 1 of the 4 linked cases reported by the same reporter.
MMR administered to pt with measles signs and symptoms appearing 3 days later. Child's mother noticed a rash on the upper body and neck of child and brought the child to the medical center for check-up by pediatrician.
Awoke with hives and itching 14 hours after taking third dose oral live virus typhoid. Treated self with oral Benadryl did not seek any other care.